查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813978

基於 CRISPR 的基因編輯市場規模、佔有率和趨勢分析報告：按產品/服務、最終用途、地區和細分市場預測，2025 年至 2033 年

CRISPR-based Gene Editing Market Size, Share & Trends Analysis Report By Product & Service (CRISPR Kits & Reagents), By Application (Biomedical, Agricultural), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

基於 CRISPR 的基因編輯市場摘要

預計 2024 年全球基於 CRISPR 的基因編輯市場價值將達到 40.1 億美元，預計 2033 年將達到 135 億美元，2025 年至 2033 年的複合年成長率為 14.7%。

這一成長是由遺傳疾病的日益普及、研究和技術的進步、政府的支持措施以及對生物技術的投資增加所推動的。

CRISPR技術及應用的進展

CRISPR 技術和應用的進步顯著加速了市場成長，提高了基因編輯的精確度、效率和多功能性。自發現以來，CRISPR-Cas 系統已從基本的 DNA 切割發展成為一個複雜的基因組工程平台。高保真度 Cas 突變體、鹼基編輯、引子編輯以及脂質奈米顆粒和病毒載體等改進的遞送機制等創新推動了 CRISPR-Cas 系統的發展。這些改進減少了脫靶效應，提高了編輯效率，並擴大了可治療疾病的範圍。與人工智慧 (AI) 和機器學習的結合進一步最佳化了嚮導 RNA 設計和目標位點選擇，從而實現了更快、更準確的開發週期。此外，該技術的適應性支持多重編輯，能夠同時修改多個基因，這對於解決複雜的疾病和性狀至關重要。

這些進步使 CRISPR 從人類治療擴展到新的應用領域，包括農業、工業生物技術、診斷和環境管理。在農業方面，CRISPR 正被用於創造適應氣候、抗蟲害和營養豐富的作物，為糧食安全挑戰提供解決方案。在診斷方面，基於 CRISPR 的工具（如 SHERLOCK 和 FELUDA）能夠快速且低成本地檢測感染疾病。同時，在合成生物學方面，CRISPR 正被用於改造微生物以實現永續的生質燃料和物質生產。 CRISPR 應用範圍的不斷擴大，加上持續的技術進步，正在吸引製藥公司、農業生物技術公司和研究機構的大量投資。這種持續的創新循環擴大了潛在市場，並加強了 CRISPR 作為跨多個產業變革性技術平台的地位。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 基於 CRISPR 的基因編輯市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場前景。
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 基於CRISPR的基因編輯市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

4.基於CRISPR的基因編輯市場：產品和服務估計和趨勢分析

  • 細分儀表板
  • 全球基於CRISPR的基因編輯市場產品與服務波動分析
  • 2021 年至 2033 年全球基於 CRISPR 的基因編輯市場規模及趨勢分析（按產品和服務）
  • 產品
    • CRISPR套件和試劑
    • CRISPR文庫
    • 其他
  • 服務

第5章基於 CRISPR 的基因編輯市場：應用估計和趨勢分析

  • 細分儀表板
  • 全球CRISPR基因編輯市場應用差異分析
  • 2021-2033 年全球 CRISPR 基因編輯市場規模及應用趨勢分析
  • 生物醫學
    • 治療進展
    • 疾病診斷
  • 農業用途
    • 工廠工程
    • 畜牧工程
    • 其他

6. 基於 CRISPR 的基因編輯市場：最終用途預估與趨勢分析

  • 細分儀表板
  • 全球基於 CRISPR 的基因編輯市場最終用途變異分析
  • 2021-2033 年全球基於 CRISPR 的基因編輯市場規模和趨勢分析（按最終用途）
  • 製藥和生物技術公司
  • 學術研究機構
  • 合約研究組織

7. 基於 CRISPR 的基因編輯市場：區域估計和趨勢分析

  • 2024 年及 2033 年區域市佔率分析
  • 區域市場儀表板
  • 市場規模、預測趨勢分析，2021-2033年：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/上市公司
    • Revvity, Inc.
    • Danaher Corporation
    • GenScript
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Tocris Bioscience
    • OriGene Technologies, Inc.
    • Bio-Rad Laboratories
    • Bio-Techne
    • New England Biolabs, Inc.
Product Code: GVR-4-68040-468-8

CRISPR-based Gene Editing Market Summary

The global CRISPR-based gene editing market size was estimated at USD 4.01 billion in 2024 and is projected to reach USD 13.50 billion by 2033, growing at a CAGR of 14.7% from 2025 to 2033. This growth is driven by the rising prevalence of genetic disorders, advancements in research and technology, supportive government initiatives, and increasing investment in biotechnology.

Advancements in CRISPR Technology & Applications

Advancements in CRISPR technology and applications are significantly accelerating market growth by enhancing precision, efficiency, and versatility in gene editing. Since its discovery, the CRISPR-Cas system has evolved beyond basic DNA cutting into a sophisticated genome engineering platform. It is supported by innovations such as high-fidelity Cas variants, base editing, prime editing, and improved delivery mechanisms such as lipid nanoparticles and viral vectors. These improvements have reduced off-target effects, increased editing efficiency, and broadened the scope of treatable conditions. Integration with artificial intelligence (AI) and machine learning has further optimized guide RNA design and target site selection, enabling faster, more accurate development cycles. Technology's adaptability also supports multiplexed editing, allowing simultaneous modification of multiple genes crucial for tackling complex diseases and traits.

These advancements also expand CRISPR into new application areas beyond human therapeutics, including agriculture, industrial biotechnology, diagnostics, and environmental management. In agriculture, CRISPR is being applied to create climate-resilient, pest-resistant, and nutrient-enhanced crops, offering solutions to food security challenges. In diagnostics, CRISPR-based tools such as SHERLOCK and FELUDA enable rapid, low-cost detection of infectious diseases. At the same time, in synthetic biology, CRISPR is used to engineer microorganisms for sustainable biofuel and material production. The widening scope of CRISPR applications, coupled with ongoing technical refinements, is attracting strong investments from pharmaceutical companies, agri-biotech firms, and research institutions. This continual innovation cycle expands the addressable market and strengthens CRISPR's position as a transformative technology platform across multiple industries.

Global CRISPR-based Gene Editing Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global CRISPR-based gene editing market based on product & service, application, end use, and region:

  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Products
    • CRISPR Kits & Reagents
    • CRISPR Libraries
    • Others
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Biomedical
    • Therapeutic Development
    • By Indication
    • Genetic Disorders
    • Oncology
    • Ophthalmology
    • Others
    • By Delivery Method
    • Ex Vivo
    • In Vivo
    • Disease Diagnostics
  • Agricultural applications
    • Plant Engineering
    • Farm Animals Engineering
    • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. CRISPR-based Gene Editing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of genetic disorders
      • 3.2.1.2. Growing investments in biotechnology and healthcare research
      • 3.2.1.3. Advancements in CRISPR technology and applications
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Ethical concerns surrounding gene editing
      • 3.2.2.2. High costs associated with CRISPR research and development
  • 3.3. CRISPR-based Gene Editing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. CRISPR-based Gene Editing Market: Product & Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global CRISPR-based Gene Editing Market Product & Service Movement Analysis
  • 4.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
  • 4.4. Products
    • 4.4.1. Products market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2. CRISPR Kits & Reagents
      • 4.4.2.1. CRISPR kits & reagents market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. CRISPR Libraries
      • 4.4.3.1. CRISPR libraries market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. CRISPR-based Gene Editing Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global CRISPR-based Gene Editing Market Application Movement Analysis
  • 5.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Biomedical
    • 5.4.1. Biomedical market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2. Therapeutic Development
      • 5.4.2.1. Therapeutic development market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.2. By Indication
        • 5.4.2.2.1. Genetic Disorders
          • 5.4.2.2.1.1. Genetic Disorders market estimates and forecasts 2021 to 2033 (USD Million)
        • 5.4.2.2.2. Oncology
          • 5.4.2.2.2.1. Oncology market estimates and forecasts 2021 to 2033 (USD Million)
        • 5.4.2.2.3. Ophthalmology
          • 5.4.2.2.3.1. Ophthalmology market estimates and forecasts 2021 to 2033 (USD Million)
        • 5.4.2.2.4. Others
          • 5.4.2.2.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.3. By Delivery Method
        • 5.4.2.3.1. Ex Vivo
          • 5.4.2.3.1.1. Ex vivo market estimates and forecasts 2021 to 2033 (USD Million
        • 5.4.2.3.2. In Vivo
          • 5.4.2.3.2.1. In vivo market estimates and forecasts 2021 to 2033 (USD Million
    • 5.4.3. Disease Diagnostics
      • 5.4.3.1. Disease diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Agricultural applications
    • 5.5.1. Agricultural applications market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.2. Plant Engineering
      • 5.5.2.1. Plant engineering market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.3. Farm Animals Engineering
      • 5.5.3.1. Farm animals engineering market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. CRISPR-based Gene Editing Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global CRISPR-based Gene Editing Market End Use Movement Analysis
  • 6.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Contract Research Organizations
    • 6.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. CRISPR-based Gene Editing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Target disease prevalence
      • 7.4.2.4. Regulatory framework
      • 7.4.2.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Target disease prevalence
      • 7.4.3.4. Regulatory framework
      • 7.4.3.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Target disease prevalence
      • 7.4.4.4. Regulatory framework
      • 7.4.4.5. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Target disease prevalence
      • 7.5.2.4. Regulatory framework
      • 7.5.2.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Target disease prevalence
      • 7.5.3.4. Regulatory framework
      • 7.5.3.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Target disease prevalence
      • 7.5.4.4. Regulatory framework
      • 7.5.4.5. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Target disease prevalence
      • 7.5.5.4. Regulatory framework
      • 7.5.5.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Target disease prevalence
      • 7.5.6.4. Regulatory framework
      • 7.5.6.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Target disease prevalence
      • 7.5.7.4. Regulatory framework
      • 7.5.7.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Target disease prevalence
      • 7.5.8.4. Regulatory framework
      • 7.5.8.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Target disease prevalence
      • 7.5.9.4. Regulatory framework
      • 7.5.9.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Target disease prevalence
      • 7.6.2.4. Regulatory framework
      • 7.6.2.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Target disease prevalence
      • 7.6.3.4. Regulatory framework
      • 7.6.3.5. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Target disease prevalence
      • 7.6.4.4. Regulatory framework
      • 7.6.4.5. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Target disease prevalence
      • 7.6.5.4. Regulatory framework
      • 7.6.5.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Target disease prevalence
      • 7.6.6.4. Regulatory framework
      • 7.6.6.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Target disease prevalence
      • 7.6.7.4. Regulatory framework
      • 7.6.7.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Target disease prevalence
      • 7.7.2.4. Regulatory framework
      • 7.7.2.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Target disease prevalence
      • 7.7.3.4. Regulatory framework
      • 7.7.3.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Target disease prevalence
      • 7.8.2.4. Regulatory framework
      • 7.8.2.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Target disease prevalence
      • 7.8.3.4. Regulatory framework
      • 7.8.3.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Target disease prevalence
      • 7.8.4.4. Regulatory framework
      • 7.8.4.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Target disease prevalence
      • 7.8.5.4. Regulatory framework
      • 7.8.5.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Revvity, Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product/Service benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Danaher Corporation
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product/Service benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. GenScript
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product/Service benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Merck KGaA
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product/Service benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Thermo Fisher Scientific, Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product/Service benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Tocris Bioscience
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product/Service benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. OriGene Technologies, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product/Service benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Bio-Rad Laboratories
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product/Service benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Bio-Techne
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product/Service benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. New England Biolabs, Inc.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product/Service benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global CRISPR-based gene editing market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 4 Global CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 6 North America CRISPR-based gene editing market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 8 North America CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 9 North America CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 10 U.S. CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 11 U.S. CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 12 U.S. CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 13 Canada CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 14 Canada CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 15 Canada CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 16 Mexico CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 17 Mexico CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 18 Mexico CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 19 Europe CRISPR-based gene editing market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 21 Europe CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 22 Europe CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 23 UK CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 24 UK CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 25 UK CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 26 Germany CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 27 Germany CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 28 Germany CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 29 France CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 30 France CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 31 France CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 32 Italy CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 33 Italy CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 34 Italy CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 35 Spain CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 36 Spain CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 37 Spain CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 38 Denmark CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 39 Denmark CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 40 Denmark CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 41 Sweden CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 42 Sweden CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 43 Sweden CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 44 Norway CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 45 Norway CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 46 Norway CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific CRISPR-based gene editing market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 51 Japan CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 52 Japan CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 53 Japan CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 54 China CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 55 China CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 56 China CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 57 India CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 58 India CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 59 India CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 60 Australia CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 61 Australia CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 62 Australia CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 63 South Korea CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 64 South Korea CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 65 South Korea CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 66 Thailand CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 67 Thailand CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 68 Thailand CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 69 Latin America CRISPR-based gene editing market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 71 Latin America CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 72 Latin America CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 73 Brazil CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 74 Brazil CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 75 Brazil CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 76 Argentina CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 77 Argentina CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 78 Argentina CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 79 MEA CRISPR-based gene editing market, by country, 2021 - 2033 (USD Million)
  • Table 80 MEA CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 81 MEA CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 82 MEA CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 83 South Africa CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 84 South Africa CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 85 South Africa CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 89 UAE CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 90 UAE CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 91 UAE CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait CRISPR-based gene editing market, by product & service, 2021 - 2033 (USD Million)
  • Table 93 Kuwait CRISPR-based gene editing market, by application, 2021 - 2033 (USD Million)
  • Table 94 Kuwait CRISPR-based gene editing market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 CRISPR-based gene editing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Market trends & outlook
  • Fig. 16 Porter's five force analysis
  • Fig. 17 PESTEL analysis
  • Fig. 18 CRISPR-based Gene editing market: Product & service outlook key takeaways
  • Fig. 19 CRISPR-based Gene editing market: Product & service movement analysis
  • Fig. 20 Products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 CRISPR kits & reagents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 CRISPR libraries market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 CRISPR-based gene editing market: Application outlook key takeaways
  • Fig. 26 CRISPR-based gene editing market: Application movement analysis
  • Fig. 27 Biomedical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Therapeutic development market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Genetic disorders market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Ophthalmology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Ex vivo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 In vivo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Agricultural applications market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Plant engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Farm animals engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 CRISPR-based gene editing market: End Use outlook key takeaways
  • Fig. 41 CRISPR-based gene editing market: End Use movement analysis
  • Fig. 42 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Academic & research Institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Contract research organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Regional marketplace outlook, 2023 & 2033 (USD million)
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 North America CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 U.S. CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Canada CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Mexico CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Europe CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 UK CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Germany CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 France CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Spain CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Italy CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Denmark CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Sweden CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Norway CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Asia Pacific CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Japan CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 China CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 India CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Australia CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 South Korea CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Thailand CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Brazil CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 South Africa CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Saudi Arabia CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 UAE CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Kuwait CRISPR-based gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Market participant categorization
  • Fig. 97 Company market position analysis, 2024
  • Fig. 98 Strategic framework